Medical Device Clinical Trials Conference Back for Eighth Consecutive Year

Chicago, IL, October 23, 2014 --(PR.com)-- The most popular conference for clinical research professionals is back with a wide range of new topics and nearly two dozen distinguished presenters speaking on the biggest issues and concerns within the medical device industry. The 8th Annual Medical Device Clinical Trials Conference will be held December 8-9, 2014 in Chicago, Illinois, bringing together directors, vice presidents, and managers of clinical affairs for two days of networking and interactive discussion on a variety of subjects.

With more than a dozen new topics on this year’s agenda, conference registrants can expect to hear case studies from companies such as Presbia, Micell Technologies, and Edwards Lifesciences, participate in open-floor discussion, and network with fellow clinical affairs and clinical research professionals. Some of the industry’s biggest names will be on hand to conduct sessions and workshops, including Raymond P. Goodrich of Terumo BCT, Kelly Bresnahan of Thoratec Corporation, and Paul Voorhorst of Depuy Synthes. Topics up for discussion will offer an in-depth look at optimizing trial design, trial site selection, and the evolving trial landscape.

Small group discussion has been built into this year’s agenda by popular request. These workshops will offer a chance for participants to discuss various scenarios that often occur when establishing a timeline and budget for an upcoming clinical trial. Groups will examine scenarios involving timeline and budget changes, controlling expanding budgets and recognizing a deviating timeline.

For more information or to register for the 8th Annual Medical Device Clinical Trials Conference, please visit www.q1productions.com/clinical-research. You can also follow us on Twitter @Q1Productions, #Q1Trials14.

About the Organizer:
Q1 Productions designs and develops webinars, training courses, conference programs and forums aimed at specifically targeted audiences throughout highly regulated industries in order to provide strategic learning and timely program content. Through a highly structured production process focused on research calls with end-users and key stakeholders in the industry, our team is able to understand the immediate business concerns of today’s leading executives. Whether focusing on new or pending legislative and health policy issues or enhanced technologies or processes that will drive efficiency, our programs provide solutions to the urgent educational and information needs of our attendees.